本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Summit Therapeutics PLC

17.55
+0.55003.24%
盤後17.700.1500+0.85%19:58 EDT
成交量:427.81萬
成交額:7,493.63萬
市值:140.01億
市盈率:-15.70
高:17.70
開:17.20
低:17.14
收:17.00
52周最高:29.23
52周最低:12.07
股本:7.98億
流通股本:1.52億
量比:0.56
換手率:2.81%
股息:- -
股息率:- -
每股收益(TTM):-1.1177
每股收益(LYR):-1.4439
淨資產收益率:-192.50%
總資產收益率:-101.61%
市淨率:22.22
市盈率(LYR):-12.15

資料載入中...

2020/06/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/21

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/15

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/04/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/26

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

超過5%披露

General statement of acquisition of beneficial ownership
2020/01/16

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/27

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

非美公司披露報告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]